Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 4 studies | 21% ± 7% | |
epithelial cell | 3 studies | 37% ± 9% | |
endothelial cell | 3 studies | 22% ± 6% | |
ciliated cell | 3 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of AKT1S1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4654.85 | 258 / 258 | 100% | 38.96 | 230 / 230 |
esophagus | 100% | 3693.51 | 1445 / 1445 | 100% | 44.16 | 183 / 183 |
liver | 100% | 3166.04 | 226 / 226 | 100% | 34.19 | 406 / 406 |
ovary | 100% | 2848.84 | 180 / 180 | 100% | 46.79 | 430 / 430 |
pancreas | 100% | 1953.22 | 328 / 328 | 100% | 31.38 | 178 / 178 |
thymus | 100% | 3177.89 | 653 / 653 | 100% | 31.13 | 605 / 605 |
brain | 100% | 2345.14 | 2638 / 2642 | 100% | 33.88 | 705 / 705 |
intestine | 100% | 3347.26 | 966 / 966 | 100% | 38.13 | 526 / 527 |
prostate | 100% | 3417.93 | 245 / 245 | 100% | 45.24 | 501 / 502 |
skin | 100% | 4685.47 | 1809 / 1809 | 100% | 45.67 | 471 / 472 |
uterus | 100% | 3294.34 | 170 / 170 | 100% | 41.60 | 458 / 459 |
kidney | 100% | 2876.65 | 89 / 89 | 99% | 28.30 | 896 / 901 |
stomach | 100% | 2998.45 | 359 / 359 | 99% | 42.41 | 284 / 286 |
bladder | 100% | 3470.10 | 21 / 21 | 99% | 40.67 | 500 / 504 |
breast | 100% | 3241.07 | 459 / 459 | 99% | 38.58 | 1108 / 1118 |
lung | 100% | 2546.35 | 576 / 578 | 99% | 33.06 | 1145 / 1155 |
adipose | 100% | 3351.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 51.90 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.39 | 29 / 29 |
muscle | 100% | 5954.83 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2386.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.23 | 1 / 1 |
blood vessel | 100% | 3011.38 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2423.83 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1501.40 | 901 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0045792 | Biological process | negative regulation of cell size |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0043523 | Biological process | regulation of neuron apoptotic process |
GO_0048011 | Biological process | neurotrophin TRK receptor signaling pathway |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031931 | Cellular component | TORC1 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0004860 | Molecular function | protein kinase inhibitor activity |
GO_0030291 | Molecular function | protein serine/threonine kinase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AKT1S1 |
Protein name | AKT1 substrate 1 Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate) |
Synonyms | PRAS40 |
Description | FUNCTION: Negative regulator of the mechanistic target of rapamycin complex 1 (mTORC1), an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth . In absence of insulin and nutrients, AKT1S1 associates with the mTORC1 complex and directly inhibits mTORC1 activity by blocking the MTOR substrate-recruitment site . In response to insulin and nutrients, AKT1S1 dissociates from mTORC1 . Its activity is dependent on its phosphorylation state and binding to 14-3-3 . May also play a role in nerve growth factor-mediated neuroprotection (By similarity). . |
Accessions | ENST00000391832.7 [Q96B36-1] ENST00000391834.6 [Q96B36-1] ENST00000391831.5 [Q96B36-1] ENST00000391835.1 [Q96B36-3] ENST00000391833.5 [Q96B36-1] ENST00000599525.1 M0R2V8 ENST00000391830.1 ENST00000344175.10 [Q96B36-1] H9KV91 Q96B36 |